AA
BMY icon

Armis Advisers’s Bristol-Myers Squibb BMY Stock Holding History

Armis Advisers’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$523K Sell
9,226
-256
-3% -$14.7K 0.05% 267
2026
Q1 		$535K Sell
9,482
-136
-1% -$7.93K 0.05% 231
2025
Q4 		$553K Buy
9,618
+5,166
+116% +$249K 0.06% 215
2025
Q3 		$205K Buy
+4,452
New +$208K 0.02% 307

Other funds holding BMY

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Armis Advisers's BMY Position: Q2 2026 in Review

Armis Advisers reduced its Bristol-Myers Squibb (BMY) stake by 2.7% in Q2 2026, selling an estimated $14.7K and leaving 9,226 shares worth $523K. The position accounts for 0.05% of the portfolio, ranked #267.

Armis Advisers first reported a position in BMY in Q3 2025 and has held it in 4 quarters since. The position peaked at $553K in Q4 2025. 548 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Armis Advisers held 9,226 shares of Bristol-Myers Squibb worth $523K as of Q2 2026.
  • Armis Advisers sold 256 Bristol-Myers Squibb shares in Q2 2026, an estimated $14.7K.
  • Bristol-Myers Squibb made up 0.05% of Armis Advisers's portfolio in Q2 2026, its #267 holding.
  • Armis Advisers first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 4 quarters since.
  • Armis Advisers's Bristol-Myers Squibb position peaked at $553K in Q4 2025.
  • 548 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Armis Advisers's 13F filing for Q2 2026, filed 7 Jul 2026.